for Immediate Release
Contact: Claire R. Wynters, Public Relations
(518) 583-0095
crwynters@criteriuminc.com
Everyone who attends the Drug Information Association’s (DIA) 44th annual meeting is invited to visit Criterium Inc.’s booth (#1201). The DIA’s 44th Annual Meeting will be held on June 22- 25, 2008 in Boston, MA at the Boston Convention & Exhibition Center.
During this meeting Ronny K. Schnel, Criterium’s Executive
Director for Business Development and Client Services will participate
in a panel discussion entitled “Lessons Learned: A Global Survey
on Outsourcing Practices.” This audience participation session
focuses on the results of a global “lessons learned” survey
of sponsor and provider views on outsourcing practices that was recently
conducted with the DIA membership. The results of the survey will
be presented, and the panelists and audience will discuss how these
results suggest ways to better design and manage outsourced projects.
It is scheduled to occur on Tuesday, June 24th from 2-3:30pm.
Criterium Inc. is a full service, global and technology driven contract research organization that offe rs a unique mix of high-quality, innovative clinical research solutions for the biopharmaceutical, and pharmaceutical, medical device and CRO industries. From thought to finish, Criterium provides timely and accurate clinical trial data and support services at every phase of development allowing customers to make sound and cost effective decisions about their clinical trials. Drug development companies can benefit from Criterium’s expertise, high-value services and products and high-end results. Founded in 1991, Criterium’s services are customized to fit each client’s specific needs, providing a seamless flow of data and information from the investigative site through Criterium back to the sponsor. To learn more about the Criterium Edge, visit the website. C riterium has corporate headquarters in Saratoga Springs, New York with offices in Florida, California, South Africa, India, Netherlands, Israel, Russia and Canada.
